Live Nasdaq Composite: Markets Take Breather After Impressive Q2 Showing on Easing Oil Outlook

Investing

Merck : MRK

All Merck Articles

1083 Articles

Jon C. Ogg | Nov 15, 2011 at 2:17 PM EST

All 30 DJIA Dividend Trends into 2012, Stock by Stock (DIA, AA, AXP, T, BAC, BA, CAT, CVX, CSCO, KO, DD, XOM, GE, HD, HPQ, IBM, INTC, JNJ, JPM, KFT, MCD, MMM, MRK, MSFT, PFE, PG, TRV, UTX, VZ, WMT, DIS)

The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain…

Paul Ausick | Oct 28, 2011 at 4:04 PM EDT

24/7 Closing Bell (AMD, FSLR, POT, PAAS, S, OXY, CVX, CSTR, MRK, BIDU, WY, IPG, SWC, ALGN, STMP, CPSI, CODE, DRIV)

Markets opened slightly lower this morning and spent the morning trying to decide on a direction. The Reuters/University of Michigan…

Douglas A. McIntyre | Oct 25, 2011 at 6:24 AM EDT

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…

Douglas A. McIntyre | Oct 24, 2011 at 6:33 AM EDT

R&D Spenders Get No Respect

A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

Douglas A. McIntyre | Sep 29, 2011 at 6:18 AM EDT

Media Digest (9/29/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke…

Jon C. Ogg | Sep 14, 2011 at 1:44 PM EDT

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month…

Jon C. Ogg | Aug 10, 2011 at 5:39 AM EDT

The 2011 Layoff Kings (BSX, CSCO, DAL, GCI, GS, HBC, LMT, MRK, RIMM, SHLD, CS, UBS, MS, ESRX, MHS)

Financial markets have been reeling as investors grow more concerned about the economy: An S&P downgrade of the full faith…

Douglas A. McIntyre | Aug 4, 2011 at 9:26 AM EDT

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability.…

Jon C. Ogg | Aug 2, 2011 at 10:01 AM EDT

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning. The…

Douglas A. McIntyre | Jul 30, 2011 at 8:14 AM EDT

National Employee Morale Day At Merck (MRK)

Merck (NYSE: MRK) released an unusual earnings announcement. It is profitable, has a bright future, and will fire about 13,000…

Jon C. Ogg | Jul 22, 2011 at 1:48 PM EDT

Top Earnings Previews For The Week Ahead (BIDU, NFLX, MMM, AMZN, BIIB, FSLR, F, JNPR, COP, GMCR, V, WFM, ALU, CHK, S, SBUX, TYC, AMGN, ITT, MRK)

Earnings season is in full throttle and many major companies are due to report in the week ahead. Some of…

Jon C. Ogg | Jun 16, 2011 at 8:10 AM EDT

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key…

Douglas A. McIntyre | May 25, 2011 at 6:33 AM EDT

Short Sellers Savage The Macro-Caps Across The Board

No industry was able to avoid short selling activity, particularly among its largest companies. Tech, automotive, conglomerates, consumer goods, and…

1 … 59 60 61 62 63 … 73

Merck : MRK

All Merck Articles

All 30 DJIA Dividend Trends into 2012, Stock by Stock (DIA, AA, AXP, T, BAC, BA, CAT, CVX, CSCO, KO, DD, XOM, GE, HD, HPQ, IBM, INTC, JNJ, JPM, KFT, MCD, MMM, MRK, MSFT, PFE, PG, TRV, UTX, VZ, WMT, DIS)

24/7 Closing Bell (AMD, FSLR, POT, PAAS, S, OXY, CVX, CSTR, MRK, BIDU, WY, IPG, SWC, ALGN, STMP, CPSI, CODE, DRIV)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

R&D Spenders Get No Respect

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Media Digest (9/29/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 2011 Layoff Kings (BSX, CSCO, DAL, GCI, GS, HBC, LMT, MRK, RIMM, SHLD, CS, UBS, MS, ESRX, MHS)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

National Employee Morale Day At Merck (MRK)

Top Earnings Previews For The Week Ahead (BIDU, NFLX, MMM, AMZN, BIIB, FSLR, F, JNPR, COP, GMCR, V, WFM, ALU, CHK, S, SBUX, TYC, AMGN, ITT, MRK)

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Short Sellers Savage The Macro-Caps Across The Board

Live Nasdaq Composite: Markets Take Breather After Impressive Q2 Showing on Easing Oil Outlook

Why Carnival’s Record Run Hasn’t Closed Its Gap with Royal Caribbean

Microsoft vs Alphabet: One Bets on OpenAI While The Other Controls Its Own AI Destiny. This Is The Better Buy Today

Wall Street’s Blue-Chip Index Just Cast Out Verizon for a Higher-Risk AI Growth Machine

At 62, Here's How to Retire to the Beaches of Palm Coast, Florida, on $3,000 a Month

Why Pulling From Your 401(k) Before Your Taxable Account Could Cost $45,000

Why Carnival’s Record Run Hasn’t Closed Its Gap with Royal Caribbean

Microsoft vs Alphabet: One Bets on OpenAI While The Other Controls Its Own AI Destiny. This Is The Better Buy Today

Merck : MRK

All Merck Articles

All 30 DJIA Dividend Trends into 2012, Stock by Stock (DIA, AA, AXP, T, BAC, BA, CAT, CVX, CSCO, KO, DD, XOM, GE, HD, HPQ, IBM, INTC, JNJ, JPM, KFT, MCD, MMM, MRK, MSFT, PFE, PG, TRV, UTX, VZ, WMT, DIS)

24/7 Closing Bell (AMD, FSLR, POT, PAAS, S, OXY, CVX, CSTR, MRK, BIDU, WY, IPG, SWC, ALGN, STMP, CPSI, CODE, DRIV)

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

R&D Spenders Get No Respect

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Media Digest (9/29/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

30-Year Auction: 12 of 30 DJIA Stocks Outyield Long Bond (T, CVX, DD, GE, INTC, JNJ, KFT, MRK, PFE, PG, TRV, VZ)

The 2011 Layoff Kings (BSX, CSCO, DAL, GCI, GS, HBC, LMT, MRK, RIMM, SHLD, CS, UBS, MS, ESRX, MHS)

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

National Employee Morale Day At Merck (MRK)

Top Earnings Previews For The Week Ahead (BIDU, NFLX, MMM, AMZN, BIIB, FSLR, F, JNPR, COP, GMCR, V, WFM, ALU, CHK, S, SBUX, TYC, AMGN, ITT, MRK)

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Short Sellers Savage The Macro-Caps Across The Board

Live Nasdaq Composite: Markets Take Breather After Impressive Q2 Showing on Easing Oil Outlook

Why Carnival’s Record Run Hasn’t Closed Its Gap with Royal Caribbean

Microsoft vs Alphabet: One Bets on OpenAI While The Other Controls Its Own AI Destiny. This Is The Better Buy Today

Wall Street’s Blue-Chip Index Just Cast Out Verizon for a Higher-Risk AI Growth Machine

Featured Reads

At 62, Here's How to Retire to the Beaches of Palm Coast, Florida, on $3,000 a Month

Why Pulling From Your 401(k) Before Your Taxable Account Could Cost $45,000